Biotage AB (publ) (STO:BIOT)

Sweden · Delayed Price · Currency is SEK

143.20

+0.20 (0.14%)

Inactive · Last trade price on Jul 21, 2025

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Small Molecules & Synthetic Therapeutics	654.00M
Small Molecules & Synthetic Therapeutics Growth	-15.06%
Biologics & Advanced Therapeutics	454.00M
Biologics & Advanced Therapeutics Growth	587.88%
Analytical Testing	415.00M
Analytical Testing Growth	8.64%
Scale-up	152.00M
Scale-up Growth	-16.02%
Water & Environmental Testing	133.00M
Water & Environmental Testing Growth	9.02%
Diagnostics	54.00M
Diagnostics Growth	17.39%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North and South America	748.00M
North and South America Growth	13.33%
EMEA	729.00M
EMEA Growth	93.88%
China	139.00M
China Growth	-40.09%
Japan	111.00M
Japan Growth	-3.48%
South Korea	60.00M
South Korea Growth	-1.64%
Other APAC	33.00M
India	27.00M
India Growth	-15.63%
Sweden	15.00M
Sweden Growth	-16.67%